{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T09:55:41Z","timestamp":1769939741674,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003154","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:05:38Z","timestamp":1461330338000},"page":"e3154","source":"Crossref","is-referenced-by-count":13,"title":["Calculation of Blood Dose in Patients Treated With 131I Using MIRD, Imaging, and Blood Sampling Methods"],"prefix":"10.1097","volume":"95","author":[{"given":"Elham","family":"Piruzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Haghighatafshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Entezarmahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-78-20210226","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/HP.0000000000000169","article-title":"One size does not fit all: The merit of absorbed doses to the blood in 131I therapy for differentiated thyroid carcinoma","volume":"108","author":"Fatholahi","year":"2015","journal-title":"Health Phys"},{"key":"R2-78-20210226","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-008-0761-x","article-title":"EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy","volume":"35","author":"Lassmann","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-78-20210226","doi-asserted-by":"crossref","first-page":"28","DOI":"10.9734\/PSIJ\/2015\/16603","article-title":"Design of a novel shield of nuclear medicine with new alloy","volume":"7","author":"Haghighatafshar","year":"2015","journal-title":"Phys Sci Int J"},{"key":"R4-78-20210226","first-page":"143","article-title":"Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software","volume":"48","author":"Kolbert","year":"2007","journal-title":"J Nucl Med"},{"key":"R5-78-20210226","first-page":"899","article-title":"Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer","volume":"46","author":"Sgouros","year":"2005","journal-title":"J Nucl Med"},{"key":"R6-78-20210226","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1677\/ERC-09-0076","article-title":"Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma","volume":"16","author":"H\u00e4nscheid","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R7-78-20210226","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"R8-78-20210226","first-page":"648","article-title":"Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal","volume":"47","author":"H\u00e4nscheid","year":"2006","journal-title":"J Nucl Med"},{"key":"R9-78-20210226","first-page":"1587","article-title":"Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer","volume":"47","author":"Tuttle","year":"2006","journal-title":"J Nucl Med"},{"key":"R10-78-20210226","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0969-8051(93)90108-7","article-title":"Predictive estimate of blood dose from external counting data preceding radioiodine therapy for thyroid cancer","volume":"20","author":"Thomas","year":"1993","journal-title":"Nucl Med Biol"},{"key":"R11-78-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ecl.2008.02.007","article-title":"An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer","volume":"37","author":"Sawka","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R12-78-20210226","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1677\/ERC-10-0071","article-title":"Dosimetry and thyroid cancer: the individual dosage of radioiodine","volume":"17","author":"Lassmann","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R13-78-20210226","first-page":"1215","article-title":"Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups","volume":"15","author":"Zakani","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R14-78-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V33.5.649.649","article-title":"Erythrocyte volume, plasma volume, and lean body mass in adult men and women","volume":"33","author":"Retzlaff","year":"1969","journal-title":"Blood"},{"key":"R16-78-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/0972-3919.164020","article-title":"Hiatal hernia uptake of iodine-131 mimicking mediastinal metastasis of papillary thyroid carcinoma","volume":"30","author":"Haghighatafshar","year":"2015","journal-title":"Indian J Nucl Med"},{"key":"R17-78-20210226","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","journal-title":"N Engl J Med"},{"key":"R18-78-20210226","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0360-3016(88)90381-1","article-title":"Papillary and follicular thyroid cancer: impact of treatment in 1578 patients","volume":"14","author":"Simpson","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-78-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V","article-title":"The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma","volume":"82","author":"Tsang","year":"1998","journal-title":"Cancer"},{"key":"R20-78-20210226","first-page":"241","article-title":"Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000","volume":"113","author":"Hay","year":"2002","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R21-78-20210226","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/jc.2003-031152","article-title":"Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients","volume":"89","author":"Bal","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-78-20210226","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00006231-200409000-00006","article-title":"The British Thyroid Association guidelines for the management of thyroid cancer in adults","volume":"25","author":"Watkinson","year":"2004","journal-title":"Nucl Med Commun"},{"key":"R23-78-20210226","first-page":"825","article-title":"Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131","volume":"39","author":"M\u2019Kacher","year":"1998","journal-title":"J Nucl Med"},{"key":"R24-78-20210226","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00006231-199910000-00008","article-title":"Estimation of risk based on biological dosimetry for patients treated with radioiodine","volume":"20","author":"Monsieurs","year":"1999","journal-title":"Nucl Med Commun"},{"key":"R25-78-20210226","first-page":"608","article-title":"The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes","volume":"45","author":"Watanabe","year":"2004","journal-title":"J Nucl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:20:30Z","timestamp":1620958830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003154","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}